Is Amneal Pharmaceuticals Inc (NASDAQ: AMRX) The Best Stock To Invest In?

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

Stocks Info

Amneal Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Amneal Pharmaceuticals Inc is $2.76B. A total of 1.93 million shares were traded on the day, compared to an average of 1.30M shares.

In the most recent transaction, BOYER ANDREW S sold 125,000 shares of AMRX for 8.89 per share on Mar 05 ’25. After the transaction, the Executive Vice President now owns 290,106 company shares. In a previous transaction on Mar 06 ’25, Daly Jason B. sold 46,936 shares at 8.73 per share. AMRX shares that EVP, Chief Legal Officer owns now total 32,606.

Among the insiders who sold shares, Daly Jason B. disposed of 43,064 shares on Mar 05 ’25 at a per-share price of $8.88. This resulted in the EVP, Chief Legal Officer holding 79,542 shares of AMRX after the transaction. In another insider transaction, Konidaris Tasos sold 100,000 shares at $8.91 per share on Mar 05 ’25. Company shares held by the Executive Vice President & CFO now total 621,882.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, AMRX has a high of $9.48 and a low of $5.18.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. AMRX’s latest balance sheet shows that the firm has $247.79M in Cash & Short Term Investments as of fiscal 2021. There were $2.88B in debt and $677.24M in liabilities at the time. Its Book Value Per Share was -$0.35, while its Total Shareholder’s Equity was $366.97M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AMRX is Buy with a score of 5.00.

Most Popular

Related Posts